Latest Patents News

Anteris Technologies reported a $22.9 million net loss in Q1 2026 but bolstered its cash position to $283 million following a $320 million capital raise. The company is scaling manufacturing and clinical activities for its DurAVR transcatheter heart valve, with US patient enrolment now underway in the pivotal PARADIGM Trial.

5E Advanced Materials secures a decade-long boric acid offtake agreement and advances boron product development, while reporting a $12.1 million quarterly loss and planning ASX delisting.

Avecho Biotechnology has bolstered its cash reserves by $1.9 million through the exercise of listed options, positioning the company for a pivotal Phase III interim analysis readout for its insomnia treatment.

American West Metals has published a detailed JORC 2012-compliant Mineral Resource Estimate for its West Desert Zinc-Copper-Indium-Magnetite Project in Utah, affirming solid resource continuity and robust sampling techniques.

Diablo Resources has acquired an 80% stake in Utah's Horn Silver Mine, a historically prolific high-grade silver asset, backed by a $3.5 million capital raise to accelerate drilling across multiple immediate targets.

MyEco Group is rolling out a new 95% post-consumer recycled bin liner range, fully certified under the Global Recycled Standard, exclusively at Woolworths stores nationwide from late May 2026. This move doubles its Woolworths product lineup and aligns with national sustainability targets.

Aquirian Limited has secured $8 million through a strongly supported placement to accelerate growth of its Drillforce business and support a major $48 million contract at the Lord Byron mine.

Diablo Resources has secured an 80% interest in the historic Horn Silver Project in Utah, a prolific high-grade silver and gold mine, supported by a $3.5 million placement to fund immediate drilling and district-scale exploration.

Janus Electric has raised A$4.5 million through a discounted private placement, aiming to accelerate battery supply, truck production, and certification efforts across Australia and North America.

BrainChip detailed significant progress in its neuromorphic AI technology and commercial strategy at its 2026 AGM, highlighting the AKD1500 chip launch and expanding defense and industrial collaborations.

Decidr AI Industries has successfully completed a $15 million placement to fund key product development and expansion initiatives, reinforcing its lead in the agentic AI sector.

Anteris Technologies has treated the first US patients in its global PARADIGM trial, marking a key milestone in testing its DurAVR transcatheter heart valve against established devices.